Monoclonal antibodies (mAbs) are appealing as potential therapeutics and prophylactics for
viral infections owing to characteristics such as their high specificity and their ability to …

Antibodies and antibody-derived macromolecules have established themselves as the
mainstay in protein-based therapeutic molecules (biologics). Our knowledge of the structure …

Antibodies play an essential role in host defence against pathogens by recognizing
microorganisms or infected cells. Although preventing pathogen entry is one potential …

Low-dimensional van der Waals (vdW) materials can harness tightly confined polaritonic
waves to deliver unique advantages for nanophotonic biosensing. The reduced …

In vitro display technologies, best exemplified by phage and yeast display, were first
described for the selection of antibodies some 20 years ago. Since then, many antibodies …

During the past decade several display methods and other library screening techniques
have been developed for isolating monoclonal antibodies (mAbs) from large collections of …

In hemophilia A, routine prophylaxis with exogenous factor VIII (FVIII) requires frequent
intravenous injections and can lead to the development of anti-FVIII alloantibodies (FVIII …

Antibodies are highly specific, naturally evolved molecules that recognize and eliminate
pathogenic and disease antigens. The past 30 years of antibody research have hinted at the …

Engineered antibodies now represent over 30% of biopharmaceuticals in clinical trials, as
highlighted by recent approvals from the US Food and Drug Administration. Recombinant …

Oil-in-water adjuvants have been shown to improve immune responses against pandemic
influenza vaccines as well as reduce the effective vaccine dose, increasing the number of …